ABBY JOHNSON: Open Payments
NPI 1396500575 · RED OAK, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$454 in 13 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $261 · 2025 $454
Food & beverage: $454
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $167 |
| Phathom Pharmaceuticals, Inc. | 1 | $51 |
| PFIZER INC. | 2 | $43 |
| INTERNATIONAL REHABILITATIVE SCIENCES, INC | 1 | $38 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| Astellas Pharma US Inc | 1 | $23 |
| Novo Nordisk Inc | 1 | $18 |
| Acella Pharmaceuticals, LLC | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
Products named: VOQUEZNA, RS-4i Plus with Intersperse, FARXIGA, VELSIPITY, Veozah, Wegovy, NURTEC ODT, NP Thyroid 60.
Industry payments across IA — which companies pay providers there.
